RACHEL FORD: Open Payments
NPI 1346652377 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 25 payments from 11 companies in 2025. Trend: 2023 $680 · 2024 $647 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $208 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Boston Scientific Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Medtronic, Inc. | 1 | $15 |
Products named: AIRSUPRA, UBRELVY, BOTOX, NATRELLE SALINE-FILLED BREAST IMPLANTS, JARDIANCE, OTEZLA, NURTEC ODT, WaveWriter Alpha Prime 16.
Industry payments across MS — which companies pay providers there.
